Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two doses of abobotulinumtoxinA for urinary symptoms in women with idiopathic overactive bladder
RBR-25k53mPhase 2Completed
- Sponsor
- Santa Casa de Misericórdia de São Paulo
- Start
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of botulinum toxin type A in overactive bladder (OAB) and urinary incontinence (UI) (2 arms), sponsored by Santa Casa de Misericórdia de São Paulo. Started Jul 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on RBR-25k53m.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-25k53m.